HRT Financial’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,400
Closed -$344K 2701
2022
Q3
$344K Buy
+6,400
New +$329K ﹤0.01% 1902
2022
Q2
Sell
-3,100
Closed -$205K 3198
2022
Q1
$205K Sell
3,100
-2,700
-47% -$185K ﹤0.01% 2476
2021
Q4
$580K Buy
+5,800
New +$600K ﹤0.01% 1643
2021
Q2
Sell
-1,500
Closed -$228K 3082
2021
Q1
$228K Buy
+1,500
New +$227K ﹤0.01% 2252

Other funds holding GH

HRT Financial's GH Position: Q1 2026 in Review

HRT Financial sold out of Guardant Health (GH) in Q1 2026, closing a stake of 77,117 shares — an estimated $7.88M sold.

HRT Financial first reported a position in GH in Q4 2020 and held it in 12 quarters. The position peaked at $11.6M in Q1 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • HRT Financial reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 77,117 Guardant Health shares in Q1 2026, an estimated $7.88M.
  • HRT Financial first reported a position in Guardant Health in Q4 2020 and held it in 12 quarters.
  • HRT Financial's Guardant Health position peaked at $11.6M in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.